Dysphagia in patients with Sporadic Inclusion Body Myositis: Management challenges
Dysphagia in patients with Sporadic Inclusion Body Myositis: Management challenges.
International Journal of General Medicine, 2019 (12), 465-474.
Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.
inflammatory myopathies, swallowing, epidemiology, pathophysiology, treatment, diagnosis